{"nct_id":"NCT02595970","title":"Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis","status":"COMPLETED","status_verified_date":"2019-04","start_date":"2015-05-20","start_date_type":"ACTUAL","primary_completion_date":"2017-02-09","primary_completion_date_type":"ACTUAL","completion_date":"2017-02-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}